Signs of an allergic reaction include severe itching or rash, hives, difficulty breathing or swallowing, lightheadedness, facial flushing, nausea, vomiting, heart palpitations, and swelling of the face, eyes, tongue, or throat
Kim YM, Reed W, Wu W, Bromberg PA, Graves LM, Samet JM
Professional medical evaluation may be appropriate when: Facial hollowing or volume loss is the primary concern Skin laxity is significant There is persistent redness, itching, pain, or a new rash Hair shedding becomes pronounced or continues for several months Dryness is severe despite a simplified routine A changing lesion or pigmented spot requires evaluation The individual is considering injectable or energy-based procedures Consumers should not stop, reduce, or change a prescribed GLP-1 medication because of cosmetic concerns without speaking with the healthcare professional managing their treatment
Cigna's prior authorization for GLP-1 weight loss medications typically requires documentation that the patient has a BMI of 30 or greater (or 27 or greater with qualifying comorbidity), has completed at least three months of a structured lifestyle modification program, and has not responded adequately to lifestyle changes alone
The mean pressure value at which the animal responded was recorded